Home LiteratureArticle Details
PMID: 18364711 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major.

Molecular systems biology ·Vol. 4 ·2008-00-00 ·Pages 177

Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA

Abstract

Systems analyses have facilitated the characterization of metabolic networks of several organisms. We have reconstructed the metabolic network of Leishmania major, a poorly characterized organism that causes cutaneous leishmaniasis in mammalian hosts. This network reconstruction accounts for 560 genes, 1112 reactions, 1101 metabolites and 8 unique subcellular localizations. Using a systems-based approach, we hypothesized a comprehensive set of lethal single and double gene deletions, some of which were validated using published data with approximately 70% accuracy. Additionally, we generated hypothetical annotations to dozens of previously uncharacterized genes in the L. major genome and proposed a minimal medium for growth. We further demonstrated the utility of a network reconstruction with two proof-of-concept examples that yielded insight into robustness of the network in the presence of enzymatic inhibitors and delineation of promastigote/amastigote stage-specific metabolism. This reconstruction and the associated network analyses of L. major is the first of its kind for a protozoan. It can serve as a tool for clarifying discrepancies between data sources, generating hypotheses that can be experimentally validated and identifying ideal therapeutic targets.

MeSH Terms
Animals Biomass Computational Biology Gene Deletion Genome, Protozoan Leishmania major/enzymology,genetics,growth & development,metabolism Life Cycle Stages Metabolic Networks and Pathways/genetics Models, Biological Proton-Translocating ATPases/metabolism Reproducibility of Results Systems Analysis
Chemicals
Proton-Translocating ATPases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Chavali Arvind K
Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Whittemore Jeffrey D
Eddy James A
Williams Kyle T
Papin Jason A
References (82)
82 references, click to expand
  1. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi.
    Int J Antimicrob Agents. 2004 Jul;24(1):72-8 PMID: 15225865
  2. Leishmania spp.: effect of inhibitors on growth and on polyamine and macromolecular syntheses.
    Exp Parasitol. 1979 Dec;48(3):464-70 PMID: 510448
  3. The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins.
    J Mol Biol. 2000 Jul 21;300(4):903-16 PMID: 10891277
  4. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network.
    Genome Res. 2003 Feb;13(2):244-53 PMID: 12566402
  5. Retention and loss of amino acid biosynthetic pathways based on analysis of whole-genome sequences.
    Eukaryot Cell. 2006 Feb;5(2):272-6 PMID: 16467468
  6. Acidocalcisomes - conserved from bacteria to man.
    Nat Rev Microbiol. 2005 Mar;3(3):251-61 PMID: 15738951
  7. Exploring genetic interactions and networks with yeast.
    Nat Rev Genet. 2007 Jun;8(6):437-49 PMID: 17510664
  8. Flux balance analysis in the era of metabolomics.
    Brief Bioinform. 2006 Jun;7(2):140-50 PMID: 16772264
  9. Strategic emphases for tropical diseases research: a TDR perspective.
    Trends Parasitol. 2002 Oct;18(10):421-6 PMID: 12377584
  10. A fatty-acid synthesis mechanism specialized for parasitism.
    Nat Rev Microbiol. 2007 Apr;5(4):287-97 PMID: 17363967
  11. Xanthine phosphoribosyltransferase from Leishmania donovani. Molecular cloning, biochemical characterization, and genetic analysis.
    J Biol Chem. 1999 Nov 26;274(48):34403-10 PMID: 10567419
  12. De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.
    Eukaryot Cell. 2007 Mar;6(3):454-64 PMID: 17220466
  13. The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function.
    EMBO J. 2005 Dec 7;24(23):4029-40 PMID: 16270030
  14. Sphingolipids are essential for differentiation but not growth in Leishmania.
    EMBO J. 2003 Nov 17;22(22):6016-26 PMID: 14609948
  15. Bacterial variations on the methionine salvage pathway.
    BMC Microbiol. 2004 Mar 04;4:9 PMID: 15102328
  16. Molecular characterization of the hexokinase gene from Leishmania major.
    J Parasitol. 2005 Dec;91(6):1504-9 PMID: 16539044
  17. Genetic analysis of purine metabolism in Leishmania donovani.
    J Biol Chem. 1997 Aug 1;272(31):19488-96 PMID: 9235951
  18. Transcription in kinetoplastid protozoa: why be normal?
    Microbes Infect. 2003 Nov;5(13):1231-40 PMID: 14623019
  19. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis.
    Nat Rev Genet. 2006 Apr;7(4):294-305 PMID: 16543933
  20. Global reconstruction of the human metabolic network based on genomic and bibliomic data.
    Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1777-82 PMID: 17267599
  21. Polyamines and the growth of leishmanial parasites.
    Med Biol. 1981 Dec;59(5-6):441-7 PMID: 7339304
  22. Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages.
    Mol Biochem Parasitol. 2006 Jul;148(1):24-30 PMID: 16597468
  23. Special organelles of some pathogenic protozoa.
    Parasitol Res. 2002 Dec;88(12):1013-25 PMID: 12444449
  24. Isolation and characterization of kinetoplast DNA from Leishmania tarentolae.
    J Mol Biol. 1971 Mar 28;56(3):443-73 PMID: 4324686
  25. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed.
    Mol Biochem Parasitol. 2007 Mar;152(1):35-46 PMID: 17188763
  26. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability.
    EMBO J. 2001 Jul 16;20(14):3657-66 PMID: 11447107
  27. Products of Leishmania braziliensis glucose catabolism: release of D-lactate and, under anaerobic conditions, glycerol.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7129-33 PMID: 3478686
  28. S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers.
    J Biol Chem. 2002 Feb 22;277(8):5902-9 PMID: 11734561
  29. Parametric sensitivity of stoichiometric flux balance models applied to wild-type Escherichia coli metabolism.
    Biotechnol Bioeng. 1995 Jan 5;45(1):69-79 PMID: 18623053
  30. The occurrence of free D-alanine and an alanine racemase activity in Leishmania amazonensis.
    FEMS Microbiol Lett. 2006 Mar;256(1):16-21 PMID: 16487314
  31. From genomes to in silico cells via metabolic networks.
    Curr Opin Biotechnol. 2005 Jun;16(3):350-5 PMID: 15961036
  32. Towards multidimensional genome annotation.
    Nat Rev Genet. 2006 Feb;7(2):130-41 PMID: 16418748
  33. Leishmaniasis: new approaches to disease control.
    BMJ. 2003 Feb 15;326(7385):377-82 PMID: 12586674
  34. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities.
    Proc Natl Acad Sci U S A. 2000 May 9;97(10):5528-33 PMID: 10805808
  35. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information.
    Mol Syst Biol. 2007;3:121 PMID: 17593909
  36. The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species.
    Mol Biochem Parasitol. 1984 Oct;13(2):159-72 PMID: 6440018
  37. Systems approach to refining genome annotation.
    Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17480-4 PMID: 17088549
  38. Leishmania species: fatty acid composition of promastigotes.
    Exp Parasitol. 1974 Dec;36(3):455-61 PMID: 4430338
  39. Host-pathogen systems biology.
    Drug Discov Today. 2006 Mar;11(5-6):220-7 PMID: 16580599
  40. THE MECHANISM OF FATTY ACID SYNTHESIS.
    Proc Natl Acad Sci U S A. 1964 Jul;52:106-14 PMID: 14192647
  41. Genetic analysis of spermidine synthase from Leishmania donovani.
    Mol Biochem Parasitol. 2001 Jul;115(2):217-26 PMID: 11420108
  42. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
    Amino Acids. 2002 Jun;22(4):297-308 PMID: 12107758
  43. Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase.
    Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5502-7 PMID: 16569701
  44. Modeling methanogenesis with a genome-scale metabolic reconstruction of Methanosarcina barkeri.
    Mol Syst Biol. 2006;2:2006.0004 PMID: 16738551
  45. Kinetoplast DNA, mitochondrial DNA with a difference.
    Mol Biochem Parasitol. 1983 Oct;9(2):93-104 PMID: 6366549
  46. Protozomics: trypanosomatid parasite genetics comes of age.
    Nat Rev Genet. 2003 Jan;4(1):11-9 PMID: 12509749
  47. Ornithine decarboxylase gene deletion mutants of Leishmania donovani.
    J Biol Chem. 1999 Feb 5;274(6):3781-8 PMID: 9920931
  48. Genome-scale metabolic model of Helicobacter pylori 26695.
    J Bacteriol. 2002 Aug;184(16):4582-93 PMID: 12142428
  49. Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms.
    Am J Trop Med Hyg. 1999 Jan;60(1):41-50 PMID: 9988320
  50. Evolutionary conservation of a microbody targeting signal that targets proteins to peroxisomes, glyoxysomes, and glycosomes.
    J Cell Biol. 1991 Sep;114(5):893-904 PMID: 1831458
  51. Cultivation of clinically significant hemoflagellates.
    Clin Microbiol Rev. 2002 Jul;15(3):374-89 PMID: 12097246
  52. Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei.
    Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5884-9 PMID: 11983889
  53. The myo-inositol-1-phosphate synthase gene is essential in Trypanosoma brucei.
    Biochem Soc Trans. 2005 Nov;33(Pt 5):983-5 PMID: 16246027
  54. Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1.
    J Bacteriol. 2008 Apr;190(8):2790-803 PMID: 18192387
  55. Genome-scale analysis of Mannheimia succiniciproducens metabolism.
    Biotechnol Bioeng. 2007 Jul 1;97(4):657-71 PMID: 17405177
  56. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110.
    Appl Environ Microbiol. 1994 Oct;60(10):3724-31 PMID: 7986045
  57. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
    Biol Chem. 2003 Apr;384(4):539-49 PMID: 12751784
  58. Reconstructing the metabolic network of a bacterium from its genome.
    Trends Microbiol. 2005 Nov;13(11):550-8 PMID: 16169729
  59. The genome of the African trypanosome Trypanosoma brucei.
    Science. 2005 Jul 15;309(5733):416-22 PMID: 16020726
  60. Mitochondrial substrate level phosphorylation is essential for growth of procyclic Trypanosoma brucei.
    J Biol Chem. 2002 Sep 6;277(36):32849-54 PMID: 12095995
  61. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):35-45 PMID: 12467972
  62. Compartmentation protects trypanosomes from the dangerous design of glycolysis.
    Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2087-92 PMID: 10681445
  63. Expression profiling using random genomic DNA microarrays identifies differentially expressed genes associated with three major developmental stages of the protozoan parasite Leishmania major.
    Mol Biochem Parasitol. 2004 Jul;136(1):71-86 PMID: 15138069
  64. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.
    Antimicrob Agents Chemother. 2001 Jul;45(7):2023-9 PMID: 11408218
  65. In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes.
    Mol Biochem Parasitol. 2006 Jun;147(2):193-206 PMID: 16546274
  66. Advances in flux balance analysis.
    Curr Opin Biotechnol. 2003 Oct;14(5):491-6 PMID: 14580578
  67. Trypanosomal dUTPases as potential targets for drug design.
    Curr Protein Pept Sci. 2001 Dec;2(4):389-97 PMID: 12374098
  68. Kinetic characterization, structure modelling studies and crystallization of Trypanosoma brucei enolase.
    Eur J Biochem. 2003 Aug;270(15):3205-13 PMID: 12869196
  69. Evolution of energy metabolism and its compartmentation in Kinetoplastida.
    Kinetoplastid Biol Dis. 2003 Oct 28;2(1):11 PMID: 14613499
  70. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR).
    Genome Biol. 2003;4(9):R54 PMID: 12952533
  71. The role of phosphomannose isomerase in Leishmania mexicana glycoconjugate synthesis and virulence.
    J Biol Chem. 2001 Mar 2;276(9):6566-75 PMID: 11084042
  72. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus.
    Mol Microbiol. 1998 Jul;29(2):653-60 PMID: 9720880
  73. The glycosomes of the Kinetoplastida.
    Biochimie. 1993;75(3-4):231-4 PMID: 8507685
  74. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages.
    EMBO J. 1997 May 15;16(10):2590-8 PMID: 9184206
  75. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids.
    Science. 1985 Mar 22;227(4693):1485-7 PMID: 3883489
  76. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants.
    J Biol Chem. 2004 May 28;279(22):23668-78 PMID: 15023992
  77. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
    Biochem J. 1992 Aug 15;286 ( Pt 1):9-11 PMID: 1355650
  78. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets.
    BMC Syst Biol. 2007 Jun 08;1:26 PMID: 17555602
  79. Leishmania spp.: cellular levels and synthesis of polyamines during growth cycles.
    Exp Parasitol. 1979 Dec;48(3):457-63 PMID: 510447
  80. ATP generation in the Trypanosoma brucei procyclic form: cytosolic substrate level is essential, but not oxidative phosphorylation.
    J Biol Chem. 2003 Dec 5;278(49):49625-35 PMID: 14506274
  81. Specific chemotherapy of Chagas disease: controversies and advances.
    Trends Parasitol. 2003 Nov;19(11):495-501 PMID: 14580960
  82. S-Adenosylmethionine in protozoan parasites: functions, synthesis and regulation.
    Mol Biochem Parasitol. 2007 Mar;152(1):1-10 PMID: 17196271
Article Info
Journal
Molecular systems biology
Abbr.
Mol Syst Biol
ISSN
1744-4292
Published
2008-00-00
Epub
2008-00-25
Pages
177
Language
English
Region
England
NLM ID
101235389
PMCID
PMC2290936
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]